These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 15330183)
1. Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer. Ranger GS; Thomas V; Jewell A; Mokbel K Anticancer Res; 2004; 24(4):2349-51. PubMed ID: 15330183 [TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139 [TBL] [Abstract][Full Text] [Related]
3. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Ristimäki A; Sivula A; Lundin J; Lundin M; Salminen T; Haglund C; Joensuu H; Isola J Cancer Res; 2002 Feb; 62(3):632-5. PubMed ID: 11830510 [TBL] [Abstract][Full Text] [Related]
5. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features. Perrone G; Santini D; Vincenzi B; Zagami M; La Cesa A; Bianchi A; Altomare V; Primavera A; Battista C; Vetrani A; Tonini G; Rabitti C Histopathology; 2005 May; 46(5):561-8. PubMed ID: 15842638 [TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148 [TBL] [Abstract][Full Text] [Related]
7. Elevated expression of cyclooxygenase-2 in breast cancer and ductal carcinoma in situ has no correlation with established prognostic markers. Ranger GS; Jewell A; Thomas V; Mokbel K J Surg Oncol; 2004 Nov; 88(2):100-3. PubMed ID: 15499599 [TBL] [Abstract][Full Text] [Related]
8. Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. Davies G; Salter J; Hills M; Martin LA; Sacks N; Dowsett M Clin Cancer Res; 2003 Jul; 9(7):2651-6. PubMed ID: 12855643 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in Hungarian breast cancer patients. Nádasi E; Anga B; Sándor J; Megyesi J; Kelemen D; Mottolese M; Natali PG; Hegedus G; Arany I; Ember I Anticancer Res; 2007; 27(1A):279-82. PubMed ID: 17352244 [TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic significance of cyclooxygenase-2 mRNA expression in human breast carcinoma]. Pang D; Zhao X; Xue Y Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):567-9. PubMed ID: 12667327 [TBL] [Abstract][Full Text] [Related]
12. Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer. Singh-Ranger G; Kirkpatrick KL; Clark GM; Mokbel K Curr Med Res Opin; 2003; 19(2):131-4. PubMed ID: 12740157 [TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer. Seo SS; Song YS; Kang DH; Park IA; Bang YJ; Kang SB; Lee HP Gynecol Oncol; 2004 Mar; 92(3):927-35. PubMed ID: 14984962 [TBL] [Abstract][Full Text] [Related]
14. Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer. Sivula A; Talvensaari-Mattila A; Lundin J; Joensuu H; Haglund C; Ristimäki A; Turpeenniemi-Hujanen T Breast Cancer Res Treat; 2005 Feb; 89(3):215-20. PubMed ID: 15754118 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of cyclooxygenase-2 is associated with breast carcinoma and its poor prognostic factors. Shim JY; An HJ; Lee YH; Kim SK; Lee KP; Lee KS Mod Pathol; 2003 Dec; 16(12):1199-204. PubMed ID: 14681319 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer. Witton CJ; Hawe SJ; Cooke TG; Bartlett JM Histopathology; 2004 Jul; 45(1):47-54. PubMed ID: 15228443 [TBL] [Abstract][Full Text] [Related]
17. Expression of cyclooxygenase-2 in malignant and benign breast tumors. Watanabe O; Shimizu T; Imamura H; Kinoshita J; Utada Y; Okabe T; Kimura K; Hirano A; Yoshimatsu K; Aiba M; Ogawa K Anticancer Res; 2003; 23(4):3215-21. PubMed ID: 12926055 [TBL] [Abstract][Full Text] [Related]
18. COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies? Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595 [TBL] [Abstract][Full Text] [Related]
19. 17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer. Oduwole OO; Li Y; Isomaa VV; Mäntyniemi A; Pulkka AE; Soini Y; Vihko PT Cancer Res; 2004 Oct; 64(20):7604-9. PubMed ID: 15492288 [TBL] [Abstract][Full Text] [Related]
20. [Expression of the cyclooxygenase-2 gene in human breast carcinoma]. Zhao XQ; Pang D; Xue YW Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):427-9. PubMed ID: 12895350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]